Eisai Co., Ltd.
Status: Publicly traded
Direct answer
Eisai Co., Ltd. is publicly traded on JPX under the ticker 4523.T.
Eisai Co., Ltd. is a Japanese pharmaceutical firm that develops, manufactures, and markets a broad spectrum of medical and healthcare products. Its significant therapeutic contributions include Aricept, prescribed for individuals with Alzheimer's disease and dementia with Lewy bodies; Methycobal, targeting peripheral neuropathy; and Fycompa, an antiepileptic medication used as an adjunctive treatment for...
Can you invest in Eisai Co., Ltd.?
Yes. Eisai Co., Ltd. trades publicly on JPX as 4523.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Eisai Co., Ltd.
Detailed equity research is provided by MarketSnap.